During the BiotechPartner meetings, entrepreneurs pitch their innovations to the partners. Below a selection of companies that have presented during the BiotechPartners pilot in 2017 can be found. For all entepreneurs that have presented their innovation in the 10 years existence of MedtechPartners, please click here.
VitroScan develops personalized diagnostics to predict drug efficacy and revolutionize treatment benefit for cancer patients.
Cyclomics introduces a novel technology to test for the recurrence of cancer at unprecedented single-molecule sensitivity.
Noviocell develops an unique technology to culture organoids in a synthetic base material, offering higher reproducibility and possible therapeutic and diagnostic applications.
Marco de Boer showed BiotechPartners their new biomolecule transduction methods.
A innovative way to solubize drugs was presented by Niall Hodgins.
Andreas Bastian showed innovative ways of creating the 21st century's first new antibiotic.
A novel electrophoresis set-up for better, faster and safer protocols, presented by founder and CTO Max Green.
Michael Ponomarenko develops a microfluidic organ-on-a-chip device for spheroid cell culture.
Dr. Daniel Girones presented Protinhi's novel antiviral therapeutics against Dengue, Zika and related viral threads.